Rheumatol Ther. 2023 Feb;10(1):95-115. doi: 10.1007/s40744-022-00493-2. Epub 2022 Oct 13.
3
Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.
免疫介导的炎症性疾病的组织非特异性药物试验的结局选择:核心结局集和监管指南的系统评价。
Trials. 2022 Jan 15;23(1):42. doi: 10.1186/s13063-022-06000-w.